Evidence map›Paper›PMID 29770094›Full record

ArticleCanada communicable disease report = Releve des maladies transmissibles au Canada2018

Travel-related Zika virus cases in Canada: October 2015-June 2017.

J Tataryn, L Vrbova, M Drebot, H Wood, E Payne, S Connors, J Geduld, M German, K Khan, P A Buck

Abstract read
In one paragraph

Article in Canada communicable disease report = Releve des maladies transmissibles au Canada, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. The Invasive Mosquitoes of Canada: An Entomological, Medical, and Veterinary Review.The American journal of tropical medicine and hygiene · 2022
    Review
  4. Article
  5. Could exotic mosquito-borne diseases emerge in Canada with climate change?Canada communicable disease report = Releve des maladies transmissibles au Canada · 2019
    Article
  6. Article
  7. Zika virus: Where to from here?Canada communicable disease report = Releve des maladies transmissibles au Canada · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

J TatarynCentre for Food-borne, Environmental and Zoonotic Infectious Diseases (CFEZID), Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Saskatoon, SK.
L VrbovaCentre for Food-borne, Environmental and Zoonotic Infectious Diseases (CFEZID), Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Toronto, ON.
M DrebotNational Microbiology Laboratory, Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Winnipeg, MB.
H WoodNational Microbiology Laboratory, Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Winnipeg, MB.
E PayneOffice of Border and Travel Health, Health Security and Infrastructure Branch, Public Health Agency of Canada, Ottawa, ON.
S ConnorsCentre for Food-borne, Environmental and Zoonotic Infectious Diseases (CFEZID), Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Toronto, ON.
J GeduldOffice of Border and Travel Health, Health Security and Infrastructure Branch, Public Health Agency of Canada, Ottawa, ON.
M GermanDepartment of Medicine, Division of Infectious Diseases, University of Toronto, Toronto, ON.
K KhanDepartment of Medicine, Division of Infectious Diseases, University of Toronto, Toronto, ON.
P A BuckCentre for Food-borne, Environmental and Zoonotic Infectious Diseases (CFEZID), Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Ottawa, ON.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundZika virus (ZIKV) is an emerging mosquito-borne disease that can cause severe birth defects if contracted congenitally. Since late 2015, there has been a large increase in the number of travel-related cases of Zika virus infection in Canada.

objectiveThe objective of this study was to describe the epidemiology of travel-related Zika cases in Canada from October 2015 to June 2017 and review them in the context of the international outbreak in the Americas.

methodsZika virus infections were confirmed by polymerase chain reaction (PCR) detection of viral RNA and/or the serological identification of ZIKV-specific antibodies in serum. Cases of ZIKV infection were identified by provincial and territorial health authorities, and reported on a regular basis to the Public Health Agency of Canada (PHAC). Case information requested included date of illness onset, age category, sex, pregnancy status, and location(s) and dates of travel. Estimates for the monthly number of Canadians travelling outside of Canada to other countries in the Americas were obtained from Statistics Canada and the International Air Transport Association (IATA). Data to produce the epidemic curves of autochthonous cases for each region of the Americas were extracted from country-specific epidemic curves on the Pan American Health Organization website.

resultsAs of June 7, 2017, 513 laboratory confirmed cases and two Zika-related birth/fetal anomalies were reported across all 10 provinces. Illness in Canadian travellers generally coincided with outbreak intensity in the country of exposure rather than travel volume. There has been no evidence of autochthonous (local) transmission in Canada. Currently, cases are on the decline both in Canada and internationally.

conclusionThe surge in Canadian ZIKV infections in 2016 was directly related to the incursion and spread of ZIKV into the Americas. Although cases are now on the decline worldwide, it remains to be seen whether a resurgence of cases in previously affected or new areas will occur. Both outbreak intensity and seasonality of ZIKV transmission should be monitored over time in order to inform the timing of public health education campaigns, as some may turn out to be more effective in the off-peak travel season when the risk of disease transmission may be higher. Ongoing education and awareness among travellers, particularly for pregnant women and those planning pregnancies, is still indicated.

Identifiers

PMID29770094
PMCPMC5937072

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.